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I n t e g r i n  b i n d i n g  t o  e x t r a c e l l u l a r  m a t r i x  p r o t e i n s  i n ­
d u c e s  f o r m a t i o n  o f  s i g n a l i n g  c o m p le x e s  a t  f o c a l  a d h e ­
s io n s .  Z y x in  c o - lo c a l i z e s  w i t h  i n t e g r i n s  a t  s i t e s  o f  c e l l-  
s u b s t r a t u m  a d h e s i o n  a n d  i s  p o s t u l a t e d  t o  s e r v e  a s  a  
d o c k in g  s i t e  f o r  t h e  a s s e m b ly  o f  m u l t i m e r i c  p r o t e i n  c o m ­
p l e x e s  i n v o lv e d  i n  r e g u l a t i n g  c e l l  m o t i l i t y .  R e c e n t l y ,  w e  
i d e n t i f i e d  a  n e w  m e m b e r  o f  t h e  z y x in  f a m i ly  c a l l e d  
T R I P 6 .  T R I P 6  i s  l o c a l i z e d  a t  f o c a l  a d h e s i o n s  a n d  o v e r ­
e x p r e s s i o n  o f  T R I P 6  s lo w s  c e l l  m i g r a t i o n .  I n  a n  e f f o r t  t o  
d e f in e  t h e  m o l e c u l a r  m e c h a n i s m  b y  w h i c h  T R I P 6  a f f e c t s  
c e l l  m i g r a t i o n ,  t h e  y e a s t  t w o - h y b r i d  a s s a y  w a s  e m p lo y e d  
t o  i d e n t i f y  p r o t e i n s  t h a t  d i r e c t l y  b i n d  t o  T R I P 6 .  T h i s  
a s s a y  r e v e a l e d  t h a t  b o t h  T R I P 6  a n d  z y x in  i n t e r a c t  w i t h  
C a s L /H E F l ,  a  m e m b e r  o f  t h e  C a s  f a m i ly .  T h i s  a s s o c i a ­
t i o n  i s  m e d i a t e d  b y  t h e  L IM  r e g i o n  o f  t h e  z y x in  f a m i ly  
m e m b e r s  a n d  t h e  S H 2  d o m a i n - b i n d in g  r e g i o n  o f  C a s L /  
H E F 1 . F u r t h e r m o r e ,  t h e  a s s o c i a t i o n  b e t w e e n  p l 3 0 Cas 
a n d  t h e  t w o  z y x in  f a m i ly  m e m b e r s  w a s  d e m o n s t r a t e d  t o  
o c c u r  i n  v i v o  b y  c o - im m u n o p r e c ip i t a t i o n .  Z y x in  a n d  C a s  
f a m i ly  m e m b e r s  m a y  c o o p e r a t e  t o  r e g u l a t e  c e l l  m o t i l i t y .
Integrin-m ediated cell adhesion to extracellular m atrix 
(ECM)1 components is crucial for m any cell activities including 
cell survival, proliferation, migration, and differentiation (1^5). 
Upon binding to the substratum , integrins recruit many cy- 
toskeletal components to the sites of cell adhesion and establish 
a structural link between the elements of the ECM and actin 
filaments. In addition to contributing to the physical link be­
tween the extracellular and intracellu lar environm ents, in te­
grin engagem ent also regulates several signaling pathways (2,
6, 7). Although the cytoplasmic domains of integrins do not 
exhibit any enzymatic activity, they can activate intracellular 
signaling pathways by recruiting a num ber of signaling pro­
teins to focal adhesions (8^10).
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Recent studies have identified a num ber of proteins th a t 
participa te in  in tegrin-dependent signaling pathw ays (10^ 
13). These signaling molecules include non-receptor tyrosine 
k inases (14, 15), serine/threonine k inases (7, 16^18), a lipid 
k inase (19), protein-tyrosine phosphatases (20^24), and 
sm all GTPases in  the Ras and Rho fam ilies (25^29). In addi­
tion to proteins th a t harbor catalytic dom ains, in tegrins re ­
cru it several adaptor proteins th a t  facilita te the assem bly of 
m ulticom ponent signaling complexes (30^32). For instance, 
upon substra tum  adhesion, the  adaptor protein p l3 0 Cas 
(pl30 " ‘ ) is recruited to integrin-rich sites where it
docks several regulatory molecules including Src, Crk, and 
FAK (focal adhesion kinase) (33^35).
Members of the zyxin family have also been postulated to 
function in integrin-m ediated signaling (36). Zyxin, the found­
ing member of the family, is a  phosphoprotein th a t is localized 
a t focal adhesions and along actin filam ents (37, 38). The 
protein displays an NH2-term inal proline-rich region, one or 
more leucine-rich nuclear export signals (depending on the 
species) and three copies of the LIM m otif a t its  COOH term i­
nus (Fig. 1A) (36, 39, 40). The NH2-term inal proline-rich region 
of zyxin displays four proline-rich repeats th a t serve as docking 
sites for M ena (mam malian Ena) and VASP (vasodilator-acti­
vated phosphoprotein) (36, 41, 42), proteins th a t are postulated 
to play an im portant role in the assembly and dynamics of actin 
filam ents (42^44). Sequences in the NH2 term inus of zyxin also 
provide a  docking site for the actin-bundling protein, a-actinin 
(45^47), fu rther bolstering a link between zyxin and elements 
of the actin cytoskeleton. Consistent w ith the possibility th a t 
zyxin plays some role in  the regulation of the actin cytoskele­
ton, targeting  of zyxin to the inner leaflet of the plasm a mem­
brane or mitochondria stim ulates actin assembly (48, 49). As is 
the case for the proline-rich sequences in the NH2 term inus of 
zyxin, the COOH-terminal LIM domains of zyxin are predicted 
to m ediate a series of protein-protein interactions (40, 50). 
Thus far, two protein binding partners for the trip le t LIM 
series in zyxin have been identified. The most NH2-terminal 
LIM domain (LIM1) of zyxin interacts w ith members of the 
cysteine-rich protein family th a t play im portant roles in muscle 
(40, 51). A second binding partne r of the LIM domains, the 
serine/threonine kinase h-warts/LATSl, was recently reported 
to in teract w ith LIM1^2 of zyxin during mitosis (52). H-wart/ 
LATS1 is a component of mitotic apparatus and negatively 
regulates Cdc2 activity (52). Evidence of an association be­
tween zyxin and a regulator of mitotic progression is consistent 
w ith the postulated role of zyxin in signaling. Moreover, a l­
though zyxin is found a t focal adhesions and faintly in the 
leading edge, it also has the capacity to shu ttle between the 
cytoplasm and the nucleus (36, 39), raising the possibility th a t 
zyxin may relay inform ation between these two com partments.


















Several years ago, a cDNA sequence th a t encoded two LIM 
domains w ith a high degree of sim ilarity to those in zyxin was 
identified in a screen for proteins th a t interacted w ith the 
thyroid hormone receptor (53). Although the physiological sig­
nificance of the interaction between the thyroid hormone re ­
ceptor and TRIP6 (thyroid receptor interacting protein 6) has 
yet to be confirmed, we became interested in the protein be­
cause of its potential relationship to zyxin. F u rthe r character­
ization of TRIP6 revealed a sim ilar domain structure to th a t of 
zyxin (54). Additionally, the subcellular distribution of exoge­
nous TRIP6 was comparable w ith zyxin (55). These observa­
tions suggest th a t TRIP6 is a member of the zyxin family.
In an effort to learn more about the function of TRIP6 and its 
relationship to zyxin, we examined the subcellular distribution 
of endogenous TRIP6, studied the effect of TRIP6 overexpres­
sion on cell m igration, and performed a two-hybrid screen to 
identify potential TRIP6-binding partners. Here we report th a t 
both TRIP6 and zyxin in teract w ith p l3 0 Cas and CasL/H EFl, 
two members of the Cas family. Cas family members, p l3 0 Cas 
(56), C asU H E F l (hum an enhancer of filam entation 1 (57, 58)), 
and Efs/Sin (embryonal Fyn-associated substrate/Src in teract­
ing protein (59, 60)), are adaptor proteins th a t play a role in cell 
motility. Co-expression of p l3 0 Cas and FAK in Chinese ham ­
ste r ovary cells increases cell m igration as compared w ith FAK 
expression alone (61). Cell m igration is also enhanced by co­
expression of p l3 0 Cas and Crk (62). This Cas-Crk mediated 
stim ulation of cell m igration is blocked by expression of 
p l3 0 Cas lacking the Crk-binding site or by expression of Crk 
lacking a functional SH2 domain. Targeted gene disruption 
studies have also dem onstrated th a t Cas is involved in  the 
regulation of cell locomotion (63, 64). The assembly of signaling 
complexes involving Cas family members has been shown to be 
crucial for norm al cellular responses to integrin engagem ent 
(65). The dem onstration th a t zyxin and Cas family members 
are present in the sam e molecular complex provides a direct 
connection between zyxin family members and Cas-dependent 
motility.
MATERIALS AND METHODS 
A ntib o d y  Preparation
Anti-TRIP6 antibody was generated in New Zealand White rabbits 
against a peptide sequence deduced from TRIP6 cDNA sequence anal­
ysis (54). The amino acid sequence l0KQPEPARAPQGRAIPR25 conju­
gated to maleimide-activated keyhole limpet hemocyanin (Pierce) was 
immunized three times by subcutaneous injections and subsequent 
intravenous injections at 4-week intervals. The anti-TRIP6 antiserum 
was affinity purified using the immunogen peptide linked to Sulfolink 
gel (Pierce) according to a method described elsewhere (66). Briefly, the 
polyclonal antiserum diluted 1:10 in 10 mM Tris, pH 7.5, was passed 
through the column, washed extensively with 10 mM Tris, pH 7.5, and 
the bound antibodies were eluted with 100 mM glycine, pH 2.5. Frac­
tions were collected in tubes containing 1 M Tris, pH 8. The antiserum 
was characterized by immunoblotting and immunoprecipitation of 
P°SJmethionine/cysteine-labeled IMR-90 cell lysates prepared under 
denaturing conditions.
Cell Labeling  a n d  Im m unoprecip ita tion
IMR-90 cells were radiolabeled with p°SJmethionine/cysteine 
(Trana5S-label; ICN Biochemicals Inc.) for immunoprecipitation under 
denaturing conditions. Metabolic labeling of cells was carried out as 
described elsewhere (67). Metabolically labeled cells were washed three 
times with PBS, lysed in 250 /ul of Laemmli sample buffer with protease 
inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 0.1 mM benzamidine, 
1 /ug/ml pepstatin A, 1 /ug/ml phenanthroline) and scraped from the 
dishes. Cell lysates were boiled for 5 min to denature the proteins and 
centrifuged at 12,000 x g  for 10 min. Immunoprecipitation was carried 
out after dilution of the supernatants in 4 volumes of modified RIPA 
buffer without SDS (50 mMTris, pH 7.6,150 mM NaCl, \%  Triton X-100,
0.5% sodium deoxycholate) supplemented with protease inhibitors. The 
lysates were precleared with protein A-agarose beads. The precleared 
lysates were then incubated for 1.5 h at 4 °C with either 5 /ul of
anti-TRIP6 antiserum or 5 /ul of corresponding preimmune serum and 
further incubated for 1 h with protein A-agarose beads. The beads were 
washed four times with modified RIPA buffer containing 0.2% SDS and 
boiled for 5 min in 2 x  Laemmli sample buffer. The immunoprecipitates 
were resolved on 12.5% SDS-polyacrylamide gels. The gels were dried 
and subjected to autoradiography.
For co-immunoprecipitation of interacting proteins from adherent 
cell lysates, IMR-90 cells grown on tissue culture dishes in DME sup­
plemented with 10% fetal bovine serum were washed two times with 
PBS and lysed in buffer A (50 mM Tris, pH 7.6, 150 mM NaCl, 1% Triton 
X-100, 0.02% SDS, 0.5 mM EDTA, protease inhibitors). After incubation 
on ice for 30 min, the lysates were centrifuged at 10,000 x g  for 15 min 
and the soluble fractions were recovered for immunoprecipitation. Ly­
sates from non-adherent cells were prepared as described elsewhere 
with a slight modification (68). Briefly, adherent cells were detached by 
trypsinization and washed twice with DME containing 1% fetal bovine 
serum. Detached cells were held in suspension for 1 h at 37 °C. Cells 
were then collected by centrifugation, washed twice with Hanks’ bal­
anced salt solution and then lysed in buffer A. The lysates were centri­
fuged at 12,000 x g  for 10 min and supernatants were collected for 
immunoprecipitation. The lysates were incubated with protein A-aga- 
rose beads for 1 h at 4 °C and precleared supernatants were collected 
after centrifugation. For the zyxin immunoprecipitation, precleared 
lysates containing 0.5 mg of protein were incubated for 2 h at 4 °C with 
5 /ul of zyxin-specific antisera or preimmune sera. For the TRIP6 im­
munoprecipitation, 1.0 mg of precleared lysates were similarly incu­
bated with 40 /ul of affinity-purified TRIP6 antibody or rabbit IgG as a 
negative control. Protein A-agarose beads were added to the mixture 
and incubated for an additional hour. The beads were washed four 
times with 1 ml of buffer A and the immunoprecipitates were eluted by 
boiling the beads in 2 x  Laemmli sample buffer for 5 min. The immu­
noprecipitates were resolved on 7.5 or 12.5% SDS-polyacrylamide gel 
and transferred onto nitrocellulose paper for immunoblotting. Zyxin 
and pl30Cat' were detected by the enhanced chemiluminescence detec­
tion method using horseradish peroxidase-linked goat anti-rabbit or 
anti-mouse immunoglobulins as a secondary reagent (Amersham Bio­
sciences, Inc.). The blots were then stripped in stripping solution (100 
mM 2-mercaptoethanol, 2% SDS, 62.5 mM Tris, pH 6.8) for 1 h at 50 °C 
and washed three times in TBS, 0.1% Tween. After stripping, the blots 
were reprobed with anti-vinculin antibody (Sigma) and developed using 
enhanced chemiluminescence.
Im m unofluorescence
Indirect immunofluorescence was performed as described previously 
(69). Briefly, cells were grown on glass coverslips coated with 100 /ug/ml 
fibronectin (Invitrogen) in DME supplemented with 10% fetal bovine 
serum. Coverslips were washed in PBS, fixed for 15 min with 3.7% 
formaldehyde in PBS, and permeabilized for 4 min with 0.2% Triton 
X-100 in PBS. After washing in Tris-buffered saline (TBS: 50 mM Tris, 
pH 7.6, 150 mM NaCl), the coverslips were incubated with primary 
antibodies at 37 °C for 60 to 120 min, washed for 15 min in TBS, and 
subsequently incubated with fluorescein isothiocyanate- or Texas Red- 
conjugated secondary antibodies. The coverslips were mounted with 
gelvatol after washing for 15 min in TBS. Primary antibodies used in 
this study included the following: an affinity purified rabbit polyclonal 
anti-TRIP6 antibody B59, a rabbit polyclonal anti-zyxin antibody B38 
(1:400), the anti-vinculin monoclonal antibody hVIN-1 (1:200; Sigma), 
monoclonal anti-FLAG antibody (1:600; Sigma), and a rabbit polyclonal 
anti-|3-galactosidase antibody (1:1000; Cappel). Secondary antibodies 
included fluorescein isothiocyanate goat anti-mouse IgG (1:250), fluo­
rescein isothiocyanate goat anti-rabbit IgG (1:500; Cappel), and Texas 
Red-goat anti-mouse IgG (1:200; Molecular Probes). Cell images were 
visualized on a Zeiss Axiophot microscope.
Expression P la sm id  C onstruction
The 5' end of the human TRIP6 sequence was used to search the 
expressed sequence tag data base with the BLAST protocol. One highly 
homologous murine cDNA clone (W58878) was obtained from Genome 
Systems (St. Louis, MO) and sequenced in its entirety. A FLAG epitope 
was engineered on the amino terminus of TRIP6 and subsequently 
subcloned into the &oRI and Not I sites of the pcDNA3.1 vector (In­
vitrogen). The construct was verified by DNA sequencing.
Transien t Transfection  o f  1 0 T 1 /2  Cells
Mouse fibroblasts (10T1/2) were plated at 3.0 x  10“ cells/60-mm dish 
-22 h prior to transfection. The cells were co-transfected with 0.5 /ug of 


















sion vector or vector containing FLAG-TRIP6 cDNA. The transient 
transfection was performed using LipofectAMINE Plus (16 /ill Plus 
reagent and 10 /ill of LipofectAMINE, Invitrogen) and cells were allowed 
to incorporate cDNA constructs for 4 h. Forty h post-transfection, cells 
were prepared for the cell migration assay or harvested in 2 x Laemmli 
sample buffer to examine TRIP6 expression by Western analysis. A 
polyclonal TRIP6 antibody directed against the murine sequence (CK- 
QPEPSRLPQGRSLPR) was utilized as the primary antibody. TRIP6 
was visualized by the enhanced chemiluminescence detection method. 
The relative amount of TRIP6 expression was quantified bv using the 
Kodak Image Station 440 CF and Kodak Digital Science ID 3.0.2 
software. Transfection efficiency was -35% as measured by X-gal 
staining.
H apto taxis M igration  A ssa y
Haptotaxis migration assays were performed as previously described 
(62). Briefly, cell migration assays were executed using modified Boy- 
den chambers (24-well cell culture inserts containing polyethylene 
terephthalate membranes, 8-/iim pores). The underside of the mem­
brane was coated overnight at 4 °C with bovine serum albumin or 
fibronectin (20 /iig/ml). The inserts were rinsed one time with PBS and 
then placed into the lower chamber containing 750 /ill of DMEM plus 
10% fetal bovine serum. Cells were harvested with trypsin/EDTA, 
washed twice using serum-free DMEM, and resuspended to 5.0 x 10° 
cells/ml. Approximately 125,000 cells were added to the top of each 
migration chamber and allowed to migrate to the underside of the 
membrane for 6 h at 37 °C, 5% C02. Nonmigratory cells on the upper 
surface of the membrane were mechanically removed with a cotton 
swab. Cells attached to the underside of the membrane were stained 
with X-gal substrate. Stained cells were photographed and counted (per 
field) with an inverted phase-contrast microscope using a x 10 objective. 
Background migration was determined by counting the number of (3-ga- 
lactosidase-expressing cells migrating on bovine serum albumin. These 
values were subtracted from the number of transfected cells migrating on 
fibronectin. Each determination represents the average of three individ­
ual wells and error bars represent the standard error of the mean.
Yeast Tw o-hybrid  Screen
Strains, Plasmids, and Libraty—The Saccharomyces cerevisiae re­
porter strain L40 (MATa his3-200 trp l-901 Ieu2-3,112 ade2 lys2- 
801am. UllA3::(IexAop)8-IacZ LYS2-.:(IexAop)4-HlS3 (70)) was used for 
screening and measurement of reporter gene expression. The yeast 
strain DY151 (also known as W303-1B, M A Ta ade2-l can l-100  his3^11 
leu2-3 trp l-1  ura3-l: (71)) was used in mating assays and to perform 
specificity test. The prev plasmid pVP16 and mouse embrvo cDNA 
library cloned into pVP16 have been described elsewhere (70). pVP16 
contains a selectable marker LEU2. The bait vector plasmid pBTM116/ 
ADE2 that contains the ADE2 gene and a selectable marker TRP1 has 
been described elsewhere (72). The bait plasmid pBTM116/ADE2- 
TRIP6LIM(l-2) was constructed by subcloning a PCR-amplified DNA 
sequence encoding the first and second LIM domains of TRIP6 (amino 
acid residues 276-393) into A’coRI site of pBTM116/ADE2. Other bait 
constructs containing each individual LIM domain, LIM(l-2), LIM(2- 
3), and LIM(l-3) of human zyxin were constructed by subcloning into 
A’coRI site of pBTM116/ADE2. pl30Ca‘ DNA fragments (the full-length 
pl30C!“ cDNA was kindly provided by Dr. T. Parsons) encoding a part 
(amino acid residues 319-471) or all of the SH2 domain-binding sub­
strate region (amino acid residues 212-525) of pl30c“  were subcloned 
into the N otl site of pVP16 and BamHI site of pBTM116/ADE2.
Library Screen—The yeast strain L40 was first transformed with 
pBTM116/ADE2-TRIP6LIM( 1-2) and isolated on selective medium 
lacking tryptophan. The yeast strain was then transformed with mouse 
cDNA library by electroporation. An estimated 5 x 10s independent 
transformants were plated on medium lacking tryptophan, leucine, 
uracil, and histidine with 45 mM 3-aminotriazole to select for cells that 
transactivate the H IS3  reporter gene. HIS+ clones were grown on 
medium lacking tryptophan and leucine for 2 days and then assayed for 
lacZ  expression after the yeast cells were transferred onto nitrocellu­
lose filter. HIS+/LacZ+ isolates were grown in tryptophan+/leucine- 
plates containing 10 mg/liter adenine to eliminate pBTM116/ADE2- 
TRIP6LIMQ-2) bait plasmid. Plasmid loss was confirmed by formation 
of red colonies and tryptophan auxotrophy. Resulting red and LEU+/ 
TRP— isolates contain only prey plasmids. LEU+/TRP- isolates were 
assayed for lacZ  expression. Yeast containing prey sequences that 
failed to activate lacZ  in the absence of the bait were then mated with 
DY151 strain containing pBTM116/ADE2, pBTM116/ADE2-Lamin, or 
original bait plasmid pBTM116/ADE2-TRIP6LIM(l-2). The diploids
were then assayed for activation of the lacZ  reporter to eliminate prey 
clones that interact nonspecifically with LexA or LexA-Lamin. The prey 
sequences that specifically interact with the TRIP6LIM(l-2) were fur­
ther tested for interaction with zyxinLIM sequences.
Q uantita tive  fi-G alaetosidase A ssa y
To measure the relative strength of each two-hybrid interaction, a 
quantitative p-galactosidase assay was performed. Yeast strains were 
grown to stationary phase in selective medium lacking tryptophan and 
leucine. The cultures were diluted in 3 ml of fresh medium (A600 -  0.2) 
and then incubated with shaking until A600 reached 0.5-0.8. Cells were 
pelleted and resuspended in the same volume of Z-buffer (60 mM 
Na2H P04, 40 mM NaH2P 0 4, 10 mM KCl, 1 mM MgS04, 40 mM 0-mer- 
captoethanol). 50 /ill of chloroform and 50 /ill of 0.1% SDS were added 
and vortexed at maximum speed for 30 s. 0.2 ml of fresh o-nitrophenyl 
^-D-galactopyranoside solution (4 mg/ml in Z-buffer) was added and 
incubated at 30 °C. The reaction was stopped by adding 0.4 ml of 1 M 
Na2C0;. when a yellow color appeared (in 10 to 30 min) and the solution 
was centrifuged at 14,000 x g  for 10 min. A420 of the supernatants was 
monitored and adjusted by timing 1.5 (initial culture volume: total 
assay volume). Specific £>-galactosidase activity (Miller units) was cal­
culated using the following formula: Miller units = A420 X 1000/(A6oo X 
incubation time (min) X culture volume (ml)).
RESULTS
Endogenous TRIP6 Is Targeted to Focal Adhesions—We have 
recently identified TRIP6 as a member of the zyxin family (54). 
To date, three members of the zyxin family have been identi­
fied: zyxin, the lipoma-preferred partn e r (LPP), and TRIP6 
(Fig. LA). As a first step to study the cellular function of TRIP6, 
polyclonal antibodies directed against amino acid residues 
10^25 of hum an TRIP6 were produced. A W estern immunoblot 
analysis shows th a t the anti-TRIP6 antiserum  specifically rec­
ognizes a protein doublet w ith apparent molecular weights of 
50,000 and 48,000 (Fig. IS , m iddle panel). The calculated mo­
lecular weight of TRIP6 based on cDNA sequence analysis is 
50,300. Similarly, th is antiserum  specifically immunoprecipi- 
ta tes  a 48^50-kDa protein doublet from a lysate of [35S]methi- 
onine/cysteine-labeled IMR-90 prepared under denaturing con­
ditions (Fig. IS , right panel). The 48^50-kDa doublet w as not 
detected by W estern immunoblot or im m unoprecipitation when 
preim m une serum  was used (Fig. IS). No splice varian ts of 
TRIP6 have been identified and thus, the doublet m ay resu lt 
from post-translational modification.
Epitope-tagged TRIP6 localizes a t focal adhesions when ex­
pressed in m am m alian cells (73). To confirm the subcellular 
localization of endogenous TRIP6, indirect immunofluores­
cence was carried out using an affinity purified antibody di­
rected against TRIP6. TRIP6 is extensively co-localized with 
vinculin a t focal adhesions in  hum an fibroblasts (Fig. 1C). The 
subcellular distribution of TRIP6 resembles th a t of zyxin and 
LPP (37, 74).
Cells Overexpressing FLAG-TRIP6 E xhibit Reduced Cell M i­
gration—Zyxin has been implicated in cell motility (46). To 
evaluate w hether TRIP6 plays a role in  cell migration, m urine 
TRIP6 was expressed in  mouse fibroblasts. Immunofluores­
cence analysis of transfected cells confirmed localization of 
epitope-tagged TRIP6 to focal adhesions (Fig. 2, A  and B). The 
am ount of TRIP6 protein was estim ated to be --5^10-fold 
higher in TRIP6-transfected cell lysates than  in vector-trans­
fected cell lysates (Fig. 2 0  as determ ined by quantita tive 
W estern blot analysis w ith a murine-specific TRIP6 antibody. 
The effect of TRIP6 expression on m igratory behavior was 
assayed using the haptotaxis migration assay (Fig. 2D). T ran­
sient overexpression of TRIP6 resulted in  an —50% decrease in 
the num ber of transfected m igrating cells (p = 0.035) using 
fibronectin as the extracellular matrix. These findings provide 
further evidence th a t TRIP6 is involved in cellular movement; 
however, molecular interactions between TRIP6 and compo­


















Fig. l.A , schematic representation illustrating molecular structures 
and sequence similarity of zyxin family proteins: zyxin, LPP, and 
TRIP6. All zyxin family members display an NH„-terminal proline-rich 
region, one or two nuclear export signal (hatched sm all boxes), and 
three copies of the LIM domain at their COOH termini. Zyxin and LPP 
contain 4 and 2 FPPPP motifs (small gray boxes), respectively. The 
FPPPP motif serves as a binding site for Mena/VASP family proteins. 
Zyxin also exhibits «-actinin-binding site (black box) within the NH„- 
terminal 40 amino acid residues. The amino acid sequence of the NH„- 
terminal region and each of the three LIM domains were compared 
individually with the sequence of zyxin and the relationship to zyxin is 
shown in percentage identity. B, characterization of the anti-peptide 
antibody B59 directed against TRIP6. Left panel, Coomassie Blue- 
stained gel showing molecular markers (lane 1) and proteins of an 
IMR-90 cell lysate (lane 2). M iddle panel, proteins from a parallel gel 
were transferred to nitrocellulose membrane and probed with the anti­
TRIPS antibody (B59) and its corresponding preimmune serum (PRE). 
A protein doublet of 50 and 48 kDa is specifically recognized by the 
anti-TRIP6 antiserum, B59. Right panel, lysates prepared from 
P°Slmethionine/cysteine-labeled IMR-90 cells were used for immuno­
precipitation using the anti-TRIP6 antibody (B59) and its correspond­
ing preimmune serum (PRE). The immunoprecipitated proteins were 
resolved on a SDS-polyacrylamide gel and visualized by autoradiogra­
phy. A protein doublet of 48 and 50 kDa is specifically immunoprecipi­
tated by the anti-TRIP6 antibody, B59. C, localization of TRIP6 a t focal 
adhesions. The subcellular localization of TRIP6 was determined by 
indirect double immunofluorescence by using an affinity-purified rabbit 
polyclonal antibody raised against TRIP6 (left panel) and a mouse 
monoclonal antibody against vinculin, used as a marker for focal adhe­
sions (m iddlepanel). TRIP6 is extensively co-localized with vinculin at 
focal adhesions. No focal adhesion staining was detected with preim­
mune serum (right panel).
Screening for TRIP6-bincling Proteins by Yeast Two-hybricl 
Method—To identify protein partners th a t m ight cooperate 
with TRIP6 to affect motility, we performed an interaction
Fig. 2. O verexpression of TRIP6 decreases cell m igration .
10T1/2 cells were transiently transfected with either empty vector or 
with vector contain ing FLAG-TRIP6 cDNA. A, localization of exogenous 
TRIP6 was detected by indirect immunofluorescence using a mouse 
monoclonal antibody against the FLAG epitope. B, transfected cells 
were identified by indirect immunofluorescence using a polyclonal an­
tibody against f!-galactosidase. C, overexpression of TRIP6 was moni­
tored by Western blot analysis. Proteins from either vector (vector) or 
FLAG-TRIP6 (TRIP6) transfected cells were separated by SDS-PAGE, 
transferred to nitrocellulose, and probed with an anti-TRIP6 antibody. 
D, the haptotaxis migration assay was utilized to monitor cell migra­
tion. Cells were allowed to migrate for 6 h on bovine serum albumin- or 
fibronectin-coated membranes. The number of migrating transfected 
cells was measured by counting cells on the underside of the membrane 
tha t coexpressed f!-galactosidase. Each determination represents the 
average of th ree individual wells and error bars represent the standard 
error of the mean. This graph  is a representative of one of five experi­
ments. The TRIP6-expressing cells show a statistically significant de­
crease in cell migration over vector-transfected cells (p = 0.0046) as 
determined by the paired Student’s t test.
screen using the yeast two-hybrid system. The LIM region 
represents the most highly conserved sequence feature among 
the th ree zyxin family members (Fig. LA) and LIM domains 
represent well characterized protein-binding sites. Therefore, 
in an effort to identify new interactive partners for TRIP6 th a t 
would likely be relevant for other zyxin family members as 
well, we focused our initial efforts on a screen for proteins th a t 
could in teract w ith the LIM region of TRIP6. We employed a 
two-hybrid screen based on the activation of two reporter genes 
H IS3  and lacZ  whose expression is driven by upstream  LexA 
DNA-binding sites.
In our initial two-hybrid screen, we tried to use the three 
COOH-terminal LIM domains of TRIP6. However, LexA- 
TRIP6LIM (l-3) alone activated reporter gene expression in 
yeast as assayed by m easuring /3-galactosidase activity (data 
not shown). Deletion of sequences encoding the th ird  LIM do­
m ain of TRIP6 reduced the activation of reporter gene expres­
sion to near background, therefore we used a LexA- 
TRIP6LIM (l-2) fusion as the bait in  our two-hybrid screen. As 
outlined in  Fig. 3A, we screened ~ 5  million independent cDNA 
clones th a t were synthesized from day 10.5 mouse embryo 
mRNA by random  priming. We isolated 29 H IS+ colonies a t 
day 3.5 and an additional 45 H IS+ colonies a t day 4.5 after 
library transform ation and plating on selective medium with 
45 mM 3-aminotriazole. Of the 74 H IS+ transform ants isolated 


















Fig. 3. A. the yeast two-hybrid method for identification of binding 
partners for the LIM regions of TRIP6 and zyxin. Schematic diagram 
illustrating the protocol for the isolation of sequences that specifically
gene expression ~20-80-fold higher than  the background level 
of LexA-TRIP6LIM(l-2). To evaluate the specificity of the two- 
hybrid interactions in yeast, we elim inated the pBTM116/ 
ADE2-TRIP6LIMU-2) bait plasmid from the 67 H IS+/LacZ+ 
colonies and the resulting strains were m ated to DY151 strains 
containing a bait plasmid encoding LexA, LexA-Lamin, or 
LexA-TRIP6LIM( 1-2). Of the 67 prey clones isolated in  the 
prim ary screen, 49 retained the ability to in teract w ith LexA- 
TRIP6LIM U-2), but did not in teract w ith LexA or LexA- 
Lamin. The cDNA inserts from each of the 49 pVP16-mouse 
cDNA plasmids were sequenced and searched for sim ilar se­
quences. All but 5 cDNA inserts represented bona fide open 
reading fram es in the correct orientations for expression. 
Twenty-eight of the rem aining 44 cDNAs were selected m ulti­
ple tim es and shared extensive sequence sim ilarity to previ­
ously identified coding sequences. The proteins isolated m ulti­
ple tim es in our screen for TRIP6-binding proteins include a 
nuclear glycoprotein gp210 (75), a highly conserved novel ORF 
(accession numbers: AL031282 (human), AE003818 (Drosoph­
ila), U18779 (yeast), AE004170 (Vibrio) and U67635 (Methano- 
coccu.s)), atrophin-l-related  protein (76), CasL/H EFl (57), tro­
pomyosin 4 (77), synaptic GTPase activating protein (78), and 
a nuclear protein SON (79) (Table I). To further characterize 
the interactions between TRIP6LIM (l-2) and the seven prey 
sequences described above, we performed quantitative fi-galac- 
tosidase assays. The yeast strains containing both LexA- 
TRIP6LIM (l-2) bait and the prey sequences show dram atically 
increased /3-galactosidase activities relative to the strains con­
taining LexA-TRIP6LIM(l-2) alone (Fig. 3B).
C asL /H E F l Interacts w ith  Both TRIP6 and  Zyxin in Yeast— 
The LIM region of TRIP6 is very sim ilar in sequence to th a t of 
zyxin. Specifically, the first and second LIM domains of TRIP6 
show 46 and 61% sequence identity  to the corresponding LIM 
domains of zyxin (Fig. 1A). Because of th is sequence similarity, 
we tested w hether zyxin could in teract w ith the seven TRIP6- 
binding partners identified in the yeast two-hybrid screen. We 
used a zyxin bait construct th a t contains all three LIM domains 
of zyxin, LexA-zyxinLIM(l-3). LexA-zyxinLIM( 1-3) did not ex­
hibit the transcriptional activities by itself or in the presence of 
VP16 DNA-binding leader sequence (Fig. 3 0 .  Interestingly, of 
the seven prey sequences th a t in teract w ith TRIP6LIM (l-2), 
only CasL/H EFl and the nuclear protein SON were able to 
activate lacZ  expression w ith LexA-zyxinLIM(l-3) (Fig. 3 0 .
Zyxin L IM (l-2 i Are Necessary and Sufficient for the CasLI 
HEF1 Interaction—We decided to focus first on the character­
ization of the interaction w ith CasL/H EFl because, of the 
seven prey sequences isolated m ultiple tim es in our screen, it 
showed the greatest capacity to in teract w ith both TRIP6 and 
zyxin in yeast. In addition, CasL/H EFl has been reported to 
localize a t focal adhesions like TRIP6 and zyxin providing 
further support th a t these interactions may be physiologically 
relevant. CasL/H EFl is a “docking” protein th a t shows se­
quence and functional sim ilarity to p l3 0 Caa. Both CasL/H EFl 
and p l3 0 Caa contain an NH2-term inal SH3 domain followed by 
an SH2-binding substra te  region and a COOH-terminal con­
served region (57, 58). Previous studies have shown th a t CasL/
interact with TRIP6LIM( 1-2,) in yeast. B. relative strength of interac­
tions between prey sequences and TRIP6LIM( 1-2,). |3-Galactosidase 
activities were measured in total lysates of yeast cells containing lacZ 
reporter. The veast cells contained bait and prev plasmids as indicated 
below the bars. (3-Galactosidase activity by TRIP6LIM( 1-2,) is also 
shown. The prey sequences are summarized in Table I. Error bam  
indicate standard deviation. C. relative strength of interactions be­
tween prey sequences and zyxinLIMC 1-3). p-Galactosidase activities 
were measured in total lysates of yeast cells containing lacZ  reporter. 
The yeast cells contained bait and prey plasmids as indicated below the 











In te r a c t io n  b e tw e e n  Z y x in  a n d  C a s  F a m ily  M e m b e rs 9585
Table I



















1 7 0 Nuclear glycoprotein gp210 (human; 91%) + + + + - Greber et al. (75)
2 4 1 Novel protein similar to yeast, worm hypothetical protein (human; 98%) + + + + -
3 4 0 CasL/HEFl (human; 87%) + + + + + + + + Law et a l  (57)
4 0 4 Atrophin-1 related protein (human; 95%) + + + + - Seki et al. (76)
5 0 3 Tropomyosin 4 (human; 95%) + + + + - Yamawaki-Kataoka et al. (77)
6 0 2 Synaptic GTPase activating protein (rat; 97%) + + + + - Kim et al. (78)
7 3 0 SON. DNA-binding nuclear protein + + + + + Shimada et al. (79)
" The number of times each sequence was isolated at day 3.5 and 4.5 after library transformation was indicated.
6 Sequence similarity to known proteins are indicated by percent identity based on blast data search.
'■ Relative strength of the interactions was measured by quantitative £>-galactosidase assay. Refer to Fig. 3. B and C.
HEF1 in teracts w ith multiple signaling components. The SH2- 
binding substra te  region recruits a Crk family adaptor protein 
called Crkl upon integrin engagem ent and the SH3 domain 
interacts w ith focal adhesion kinase pp l25FAK (57, 80). The 
COOH-terminal conserved region interacts w ith the v-Abl ty ­
rosine kinase in  transform ed NIH3T3 cells (57). CasL/H EFl 
and p l3 0 Cas have been suggested to play a central role in 
assembly and coordination of intracellular signaling compo­
nents a t focal adhesions (57).
We first tested which region of zyxin is required for the 
interaction w ith CasL/H EFl. We used a series of LexA fusion 
constructs containing sequences encoding individual or m ulti­
ple LIM domains from zyxin (Fig. 4A) to m ap the sequences 
necessary for interaction w ith CasL/H EFl. W estern immuno­
blot analysis of the yeast cell lysates using a polyclonal an ti­
body directed against LexA showed th a t all the LexA-zyxinLIM 
fusion constructs were expressed a t comparable levels (data not 
shown). As can be seen in Fig. 4B, no individual LIM domain is 
sufficient to support robust binding to CasL/H EFl. Rather, 
multiple LIM domains appear necessary, w ith LIM (l-2) show­
ing greater activity th an  LIM(2-3).
CasL/H EFl is a m em ber of the Cas family th a t includes 
p l3 0 Cas and Efs/Sin. All th ree members display sim ilar se­
quence and molecular structure w ith an NH2-term inal SH3 
domain, m ultiple YXXP motifs th a t serve as SH2 domain- 
binding sites, and a COOH-terminal conserved region (56-60) 
(Fig. 5). All of the CasL/H EFl clones isolated in the yeast 
two-hybrid screen encode a p a rt of the SH2 domain-binding 
region and contain 7 out of the 13 YXXP motifs present in 
full-length CasL/H EFl (Fig. 5). The SH2 domain-binding sub­
stra te  region of p l3 0 Cas contains 15 YXXP sequences and is 
about 55% sim ilar to th a t of C asL /H E Fl. Because of these 
structural features and the sequence sim ilarity of p l3 0 Cas to 
CasL/H EFl, we tried to te s t if  the substra te  region of p l3 0 Cas 
could in teract w ith the LIM regions of TRIP6 and zyxin in the 
yeast. However, it was not possible to te s t the ability of p l3 0 Cas 
to in teract w ith TRIP6 or zyxin using the yeast two-hybrid 
screen because of protein instability of the VP16-pl30Cas fusion 
protein and intrinsic transcriptional activity of LexA-pl30Cas 
fusion proteins containing the substrate region of p l3 0 Cas (data 
not shown).
Zyxin Fam ily Members Are Associated with p l3 0 Cas in M am ­
m alian Cells—To examine the interactions between the zyxin 
and the Cas family members in  vivo, we performed co-immu- 
noprecipitation experiments with lysates from IMR-90 hum an 
fibroblasts. The anti-zyxin antibody (B38) was raised against a 
peptide derived from hum an zyxin. By W estern immunoblot 
analysis, th is antibody recognizes zyxin, which m igrates a t 
—80 kDa. We recently determ ined th a t th is antibody also rec­
ognizes the closely related zyxin family member, LPP (data not 
shown). Im portantly, the B38 anti-zyxin antibody does not
cross-react w ith p l3 0 Cas (Fig. 6A). As can be seen in Fig. 6B  
(lane 1), p l3 0 Cas is present in im m unoprecipitates performed 
under nondenaturing conditions using the anti-zyxin antibody. 
p l3 0 Cas is not detected when the preim m une serum  is used in 
these native im m unoprecipitation experiments (Fig. 6B, lane 
2). The recovery of p l3 0 Cas in the im m unoprecipitate with 
zyxin is specific as evidenced by the fact th a t vinculin, another 
cytoskeletal protein present in the lysate is not present in  the 
precipitated complex w ith zyxin and p l3 0 Cas. Similarly, 
p l3 0 Cas is present in protein complexes recovered by native 
im m unoprecipitation using anti-TRIP6 antibody but not con­
trol IgG (Fig. 6C).Vinculin is not present in either the an ti­
zyxin, anti-TRIP6, or control im m unoprecipitates, illustrating 
the specificity of the recovery of p l3 0 Cas. Im portantly, all of 
these imm unoprecipitates were performed using norm al cell 
lysates, not ones in which proteins of in terest were overex­
pressed. These data  provide compelling evidence th a t p l3 0 Cas 
is associated in vivo w ith zyxin and TRIP6. We were not able to 
detect CasL/H EFl in the hum an fibroblast cells used for these 
im m unoprecipitation studies so it was not possible to assess 
the association of CasL/H EFl w ith zyxin family members u n ­
der these conditions.
Zyxin and p l3 0 Cas Are Associated in a Cell Adhesion-inde­
pendent M anner—As discussed above, both zyxin and p l3 0 Cas 
are components of focal adhesions. The role of p l3 0 Cas in inte- 
grin-m ediated signaling pathways has been extensively stu d ­
ied. It is reported th a t the tyrosine phosphorylation levels of 
p l3 0 Cas are regulated by cell adhesion to the ECM (81, 82) and 
some of the protein-protein interactions involving p l3 0 Cas are 
regulated by cell adhesion and tyrosine phosphorylation (32, 
35). To te s t w hether zyxin and p l3 0 Cas in teract in an adhesion- 
dependent m anner, we performed a co-immunoprecipitation 
assay using the anti-zyxin antiserum  (B38) and compared the 
ability of zyxin to associate w ith p l3 0 Cas from the lysates of 
adherent versus detached IMR-90 fibroblasts. As shown in Fig.
7, comparable am ounts of p l3 0 Cas are detected in the im m u­
noprecipitates prepared from equivalent am ounts of to tal pro­
tein derived from adherent and suspended cells. Preim m une 
serum  fails to precipitate p l3 0 Cas from either adherent or sus­
pended cells. A comparable am ount of zyxin was precipitated 
from the lysates of adherent and suspended cells. These data 
suggest th a t the interaction between zyxin and p l3 0 Cas is cell 
adhesion-independent.
p l3 0 Cas Is N ot Necessary for the Targeting o f Zyxin to Focal 
Adhesions—Recently it has been determ ined th a t the LIM re­
gion of zyxin is both necessary and sufficient for targeting of 
zyxin to focal adhesions. Furtherm ore, a t least two LIM do­
mains, either LIM (l-2) or LIM(2-3), are required for focal 
adhesion localization of zyxin (83). Because the interaction 
between members of the zyxin family and the Cas family is 


















Fig. 4. A, schematic representation of the LIM domains of TRIP6 and 
zyxin fused to LexA. The TRIP6LIM(l-2> fusion construct was initially 
used for screening of the mouse embryo cDNA library. Prey sequences 
isolated in the screen were further tested for interaction with LexA- 
zyxinLIM( 1-3,) fusion. LexA fusion constructs containing one or two 
LIM domains of zyxin were used to determine the zyxin region that is 
required for the interaction with prey sequence 3 (CasL/HEFl,). B, 
relative strength of the two-hybrid interactions between zyxin LIM 
domains and CasL was measured by quantitative p-galactosidase assay 
of the yeast cells. The yeast cells contained VP16/CasL and zyxin LIM 
fusion sequences as indicated below the bars.
we examined w hether zyxin’s ability to in teract with p l3 0 Ca3 is 
critical for its recruitm ent to focal adhesions. To evaluate this 
possibility, we have compared the subcellular distributions of 
zyxin in  mouse fibroblasts derived from wild-type and p l3 0 Ca3- 
null mice. During the early stages of wild-type cell spreading, 
zyxin is found in focal adhesions, along actin stress fibers, and 
in punctate structures a t the leading edge (Fig. 8A). The punc­
ta te  structures along the leading edge are focal complexes, 
adhesive structures th a t are typically found a t  the base of 
ruffling lamellipodia (84). No difference in protein composition
has yet been reported between focal adhesions and focal com­
plexes (85). However, focal complexes are morphologically dis­
tinct from focal adhesions in th a t focal complexes display small 
punctate or oblong structures. In addition, focal complexes are 
highly dynamic relative to focal adhesions (84). In wild-type 
cells, m em brane protrusion is associated w ith the formation of 
zyxin-containing focal complexes a t  the leading edge. In 
p l3 0 Ca3-deficient cells, zyxin is prom inently localized a t  focal 
adhesions. However, zyxin-rich focal complexes are not de­
tected in p l3 0 Ca3-deficient cells (Fig. 8B). S taining w ith an 
anti-vinculin antibody likewise failed to reveal the presence of 
focal complexes along the leading edge in p l3 0 Ca3-deficient 
cells, although the cells clearly display m em brane protrusion 
beyond focal adhesions (data not shown). This resu lt demon­
stra tes th a t p l3 0 Caa is not necessary for the focal adhesion 
targeting  of zyxin. The absence of detectable focal complexes in 
the p l3 0 Ca3-deficient cells supports a role for Cas in assembly, 
maintenance, or dynamics of focal complexes.
DISCUSSION
Based on sequence sim ilarity and overall molecular struc­
ture, we have previously identified TRIP6 as a member of the 
zyxin family. In th is study, we report th a t like zyxin, endoge­
nous TRIP6 is localized a t focal adhesions. We also demon­
stra te  th a t overexpression of TRIP6 resu lts in decreased cell 
migration. To define possible molecular mechanisms by which 
TRIP6 influences cell motility, the yeast two-hybrid system 
was utilized to identify TRIP6-binding partners. This study 
revealed th a t both TRIP6 and zyxin are able to in teract with 
the Cas family of focal adhesion proteins. The interactions are 
m ediated prim arily by L IM (l-2) of TRIP6 and zyxin. The LIM 
region is the most conserved region among zyxin family mem­
bers (Fig. LA). L IM (l-2) region of TRIP6, used in our two- 
hybrid screen, is more closely related to th a t of LPP than  to 
zyxin. Specifically, LIM1 and LIM2 of TRIP6 display 61 and 
11% sequence identity  to the corresponding LIM domains of 
LPP and 46 and 61% sequence identity to those of zyxin. In 
fact, most of the amino acid residues of L IM (l-2) conserved 
between TRIP6 and zyxin are conserved in LPP. This struc­
tu ra l feature as well as focal adhesion localization of LPP 
suggests th a t LPP m ay be able to in teract w ith the Cas family 
members. Thus it  will be of in terest to te s t w hether LPP can 
in teract with Cas family proteins and to study the general role 
of the zyxin family in  the regulation of Cas-mediated signaling 
events.
One specific function associated with the LIM region of the 
zyxin family is targeting to the focal adhesion. In a recent 
study, Nix and colleagues (83) have shown th a t the LIM region 
of zyxin is both necessary and sufficient for the targeting of 
zyxin to focal adhesions w hereas the proline-rich N H2-term inal 
region alone is targeted  to the leading edge. At least two copies 
of the LIM domains, L IM (l-2) or LIM(2-3), are required for 
focal adhesion targeting  (83). These results raised the possibil­
ity th a t focal adhesion components th a t in teract with the LIM 
region of zyxin, such as p l3 0 Caa, are good candidates to recruit 
zyxin and its related sequences to focal adhesions. However, 
zyxin’s localization a t focal adhesions and along the actin cy­
toskeleton was not affected in the p l3 0 Ca3-deficient cells. LPP 
also retained the ability to localize a t focal adhesions (data not 
shown). The localization of TRIP6 in p l3 0 Ca3-deficient cells 
could not be tested because our anti-TRIP6 antibody fails to 
recognize m urine TRIP6. Our results indicate th a t p l3 0 Ca3 is 
not absolutely required for focal adhesion localization of zyxin 
and LPP. I t rem ains a  possibility th a t the p l3 0 Ca3-related 
proteins, CasL/H EFl and/or Efs/Sin, m ay compensate for the 
loss of p l3 0 Ca3 and play a role in targeting of zyxin family 
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Fig. 5. Amino acid  sequence of th e  p rey  sequence 3 deduced  from  nucleo tide  sequence analysis. The prey sequence 3 encodes a region 
of the SH2 domain-binding substrate region of CasL/HEFl. The region contains seven YXXP motifs (in bold) th a t may be recognized by the SH2 
domains when tyrosine phosphorylated. Numbers indicate the amino acid positions in the full-length CasL/HEFl.
Fig. 6. The association  o f zyxin and  TR.IP6 w ith  p l3 0 Ca,s in  hu m an  fib rob lasts. A, by Western immunoblot analysis of total IMR-90 
proteins (L). the anti-zyxin antibody recognizes zyxin/LPP at ~80 kDa and does not cross-react with pl30Ca“. B  and C'. cell lysates from IMR-90 
human fibroblasts contain pl30ca“ tha t can be detected by Western blot as a high molecular weight doublet (panels B  and C, lane L). Such lysates 
were incubated with anti-zyxin antibody (Panel B, lane 1). anti-zyxin preimmune serum (panel B, lane 2). anti-TRIP6 (panel C, lane 1). or 
anti-TRIP6 preimmune serum (panel C. lane 2) and the resulting immunoprecipitates were probed with anti-Cas antibody (upper panels) or 
anti-vinculin antibody (loioer panels). pl30Ca“ is specifically recovered in the immunoprecipitated complex recovered with anti-zyxin and 
anti-TRIP6 antibodies. The absence of vinculin in the immunoprecipitates illustrates tha t the co-precipitation of pl30Ca“ with zyxin and TRIP6 is 
specific.
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Fig. 7. The association  o f zyxin and  p l3 0 c“s is n o t d ep enden t 
on cell adhesion. Cell lysates prepared from adherent or detached 
IMR-90 cells were immunoprecipitated with the antiserum against 
zyxin. B38. or corresponding preimmune serum (PRE). The immuno­
precipitated proteins were analyzed with an anti-pl30Ca“ antibody or 
the B38 anti-zyxin antiserum.
Although the L IM (l-2) regions of zyxin and TRIP6 bind to 
the substra te  region of the Cas family th a t contains a num ber 
of tyrosine phosphorylation sites, the interaction does not seem 
to require tyrosine phosphorylation. A num ber of studies have 
dem onstrated th a t tyrosine phosphorylation of Cas family pro­
teins is enhanced upon cell adhesion to ECM (81, 82). In our 
study, we dem onstrated th a t the association between zyxin and 
p l3 0 Cas is not enhanced by cell adhesion to ECM, an observa­
tion th a t suggests th a t the association is independent of the 
p l3 0 Cas tyrosine phosphorylation status. Furtherm ore, be­
cause budding yeast exhibit very low levels of tyrosine kinase 
activity, it is unlikely th a t interactions detected in  yeast two- 
hybrid screens would be dependent on th is modification (86).
The CasL/H EFl sequence we isolated in  the yeast two hybrid 
screen exhibits seven YXXP motifs including five of seven con-
*
Fig. 8. The subce llu la r localization  of zyxin in  p l3 0 c“s-defi- 
c ien t cells. Mouse fibroblasts derived from wild type (A) and pl30Ca“- 
deficient (B) mice were plated on fibronectin-coated coverslips and the 
subcellular localization of zyxin was determined by an indirect immu­
nofluorescence method. In wild-type cells, zyxin is localized a t focal 
adhesions and focal complexes along the leading edge. However, zyxin 
staining at focal complexes is not detected in pl30Ca“-deficient cells.
sensus sequences for binding to the Crk SH2 domain (57). 
Interestingly, th is resu lt raises the possibility th a t the binding 
site for zyxin and TRIP6 on p l3 0 Cas may overlap w ith Crk’s- 
binding site. If  so, zyxin and TRIP6 may be involved in  the 
regulation of the Cas-Crk interaction and therefore, down­
stream  signaling pathways. Cas-Crk association has been dem ­
onstrated to play an im portant role in  m em brane ruffling and 
cell m igration on ECM by activating the Rac signaling pathway 
(62). D ata presented in  th is report establishes th a t overexpres­
sion of TRIP6 inhibits cell migration. One reasonable hypoth­
esis based on these observations is th a t overexpression of 
TRIP6 results in excessive sequestration of cellular p l3 0 Cas, 


















downstream signaling events. O ur data  are consistent w ith the 
hypothesis th a t TRIP6 can inhibit cell m igration by disrupting 
Cas/Crk signaling; however, other experim ents will be neces­
sary to te s t th is model. For example, in future work, it will be 
im portant to determ ine if Cas/Crk/TRIP6 can co-exist in a 
macromolecular complex and to explore w hether TRIP6 over­
expression has any effect on the Cas-Crk interaction.
Focal adhesions persist in p l3 0 Cas-deficient cells; however, 
by either anti-zyxin or anti-vinculin staining (data not shown), 
focal complex structures a t the leading edge are absent. Based 
on th is observation, p l3 0 Cas appears to be essential to m aintain 
a typical ratio of focal complexes to focal adhesions. A recent 
study revealed th a t focal complex and focal adhesion formation 
is regulated by two distinct signaling pathways, the Rac and 
Rho pathways (85). Focal complex formation is initiated by 
activation of the Rac pathway and is independent of Rho, which 
plays an im portant role in  the assembly of focal adhesions and 
actin stress fibers (84). Rac and Rho pathways are m utually 
antagonistic in focal complex and focal adhesion assembly (85). 
Down-regulation of Rho activity leads to the up-regulation of 
Rac activity and thus shifts the adhesion pattern  from focal 
adhesions to focal complexes. In  contrast, down-regulation of 
Rac resu lts in the loss of focal complexes and the growth of 
Rho-mediated focal adhesions. Based on th is m utual antago­
nism  between the Rho and Rac pathways, the apparent ab­
sence of focal complexes a t the leading edges of p l3 0 Cas-null 
cells raises the possibility th a t p l3 0 Cas may play a role as a 
positive regulator of the Rac signaling pathway and focal com­
plex formation. In  support of th is possibility, it has been dem­
onstrated th a t p l3 0 Cas-mediated cell m igration requires the 
adaptor protein Crk (62) and the association of p l3 0 Cas and Crk 
leads to the activation of the Rac-JNK (c-Jun NH2-term inal 
kinase) signaling pathway (87, 88). Thus deletion of p l3 0 Cas 
may lead to the up-regulation of Rho activity and the prefer­
ential establishm ent of focal adhesions. Since zyxin family 
members can associate directly w ith Cas proteins, they may 
cooperate w ith Cas family members to regulate cell adhesion 
and motility.
Acknoivledgmentx—We acknowledge the expert graphics and edito­
rial advice of Diana Lim and Jenny Jensen.
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